Session date: 
Wednesday, May 12, 2021 - 12:00pm to 1:00pm

Christopher Flowers, MD

Chair, Professor, Department of Lymphoma/Myeloma

University of Texas MD Anderson Cancer Center in Houston, Texas


Flowers currently serves as the Division Head ad interim, for the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Flowers joined MD Anderson as Chair of the Department of Lymphoma/Myeloma in August 2019. Previously, Dr. Flowers was the professor of Hematology and Oncology with a joint appointment in Biomedical Informatics at Emory University School of Medicine in Atlanta. From 2006-2019, he served as director of the Emory Healthcare – Lymphoma Program at Winship Cancer Institute and, from 2015-2019, as scientific director of Research Informatics - Winship Cancer Institute.


Flowers earned his medical degree from Stanford University School of Medicine where he also completed an MSc in Medical Informatics to gain expertise developing information systems to improve clinical research. He completed his internship and residency in Internal Medicine from the University of Washington in Seattle, where he continued his research training as a fellow in the Robert Wood Johnson Clinical Scholars Program and earned a second master’s degree in Pharmaceutical Outcomes Research and Policy. During this time, he also completed his fellowship in Medical Oncology from the Fred Hutchinson Cancer Research Center.


An internationally recognized expert in lymphoma clinical care, epidemiology and outcomes research, Flowers is an innovator who has a passion for facilitating new drug development. He is an active clinician who conducts clinical research involving cancer outcomes, cancer informatics, and phase 1/2 trials, focusing on the clinical development of novel therapeutics for B-cell lymphomas. His broader research interests include patient-oriented research in lymphoma and computer microsimulation models and cost-effectiveness analyses aimed at developing strategies to individualize care for cancer patients and improve systems of care. His work has resulted in more than 200 peer-reviewed publications. He has received peer-reviewed funding from foundations and the NIH including leading two U01 awards and two multi-institutional team science grants.


Active in his profession, Flowers has served in many capacities, including for national professional societies and was elected to membership in the American Society of Clinical Investigation. Of particular note is his service in the American Society of Clinical Oncology (ASCO), in which he has served as chair the ASCO guidelines on management of febrile neutropenia and chair of the ASCO Health Disparities Committee. In 2018, he was named a Fellow of ASCO.


Bluemle Life Sciences Building
233 South 10th Street
Conference Room 101
Philadelphia, PA 19107
United States
Session Summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
  • 1.00 CNE
  • 1.00 PA

Please login or register to take this course.